SYSCHEM (INDIA)
Back to Cashflow Statement
|
SYSCHEM (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹34 Cr | ₹32 Cr | ₹11 Cr | ₹-0.28 Cr | ₹-0.06 Cr |
What is the latest Cash Flow from Financing Activities ratio of SYSCHEM (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹-0.28 Cr |
| Mar2021 | ₹-0.06 Cr |
How is Cash Flow from Financing Activities of SYSCHEM (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 6.85 | |
| Mar2024 | ₹32 Cr | 196.01 | |
| Mar2023 | ₹11 Cr | Positive | |
| Mar2022 | ₹-0.28 Cr | Negative | |
| Mar2021 | ₹-0.06 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹211.4 Cr | 6.9% | 3.9% | 1.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | 6.9% |
3.9% |
1.8% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses